Aardvark Therapeutics (AARD) Interest Income - Total (2024 - 2026)

Aardvark Therapeutics (AARD) has 3 years of Interest Income - Total data on file, last reported at $889000.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Income - Total fell 24.34% year-over-year to $889000.0; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 39.21% YoY), and the FY2025 full-year result was $5.1 million, up 112.88% from the prior year.
• Interest Income - Total slipped to $889000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Interest Income - Total ranged from a high of $1.5 million in Q2 2025 to a low of $103000.0 in Q1 2024.
• A 3-year average of $938000.0 and a median of $1.0 million in 2024 frame the typical range for Interest Income - Total.
• Across the five-year window, Interest Income - Total soared 1040.78% in 2025 and retreated 24.34% in 2026, its largest moves.
• Tracing AARD's Interest Income - Total over 3 years: stood at $717000.0 in 2024, then jumped by 56.9% to $1.1 million in 2025, then fell by 20.98% to $889000.0 in 2026.
• Business Quant data shows AARD's Interest Income - Total at $889000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.